Rising Incidence of Influenza Diseases and Favorable Government Initiatives are Likely to Impel the Growth of Influenza Vaccine Market in Future
The global influenza vaccine market is segmented into product type such as conjugate vaccines, live attenuated vaccines, inactivated and subunit vaccines, toxoid vaccines and recombinant vaccines. Increasing prevalence of influenza infection and growing awareness amongst the populations regarding influenza vaccines are fueling the demand for influenza vaccines across the globe. In addition to this, recombinant vaccines are approved for people of 18 years age and older including pregnant women. Global influenza vaccine market is expected to register a 7.9% CAGR over the forecast period. Moreover, the global influenza vaccine market was valued at USD 30.4 Billion in 2015 and is expected to reach at notable revenue of USD 42.2 Billion by the end of 2021. The market is expected to expand on the back of increasing demand for influenza vaccines to protect adults and children at risk of flue and its complications. Additionally, increasing number of people suffering from influenza diseases...